4//SEC Filing
Kelley Kenneth J 4
Accession 0001179110-20-011448
CIK 0001159036other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 5:43 PM ET
Size
6.4 KB
Accession
0001179110-20-011448
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Sale
Common Stock
2020-11-27$41.25/sh−10,000$412,500→ 266,711 total - Sale
Common Stock
2020-11-25$41.50/sh−9,671$401,350→ 276,711 total
Footnotes (1)
- [F1]Represents a weighted average sales price per share. These shares were sold at prices ranging from $41.50 to $41.5102. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001291219
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 5:43 PM ET
- Size
- 6.4 KB